ArticleData in brief2025
DiaBD: A diabetes dataset for enhanced risk analysis and research in Bangladesh.
Article in Data in brief, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A clinical dataset on type-2 diabetes including demographic, anthropometric, and biochemical parameters from Bangladesh.Data in brief · 2026Article
- Few-Shot Transfer Learning for Diabetes Risk Prediction Across Global Populations.Medicina (Kaunas, Lithuania) · 2025Article
- DOSAGE: Dataset for Optimized Safe Antibiotic Guidelines and Estimates.Scientific data · 2025Article
- DiaBD: A diabetes dataset for enhanced risk analysis and research in Bangladesh.Data in brief · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes is a chronic condition affecting millions worldwide and severely impacts health and quality of life. According to the International Diabetes Federation (IDF), over 463 million adults, which is 9.3% of the global population, live with diabetes. Diabetes ranks among the most prevalent chronic diseases and was the ninth-leading cause of mortality in 2019, with 4.2 million deaths reported. This article introduces DiaBD, a novel dataset of 5,288 patient records from Bangladesh, designed to address critical gaps in diabetes research and aid in healthcare planning, risk analysis, and predictive modelling. The dataset comprises 14 attributes including age, gender, clinical vitals (pulse rate, systolic and diastolic blood pressure, glucose levels), anthropometrics (height, weight, body mass index (BMI)), family history of diabetes and hypertension, cardiovascular disease (CVD), and stroke, with a dependent attribute, Diabetic, indicates whether an individual has diabetes or not. The dataset ensures demographic diversity and precise measurements, supporting the study of diabetes and its related health issues. Features like CVD and stroke enable broader research on comorbidities. This dataset facilitates machine learning applications, risk assessment, and personalized healthcare strategies. Researchers can explore the links between diabetes, hypertension, CVD, and stroke, while healthcare providers and policymakers can leverage DiaBD to identify trends, allocate resources efficiently, and enhance public health strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.